Articles

DeepSeek’s appearance is changing the AI landscape in more ways than we might think.

Dr. Victor Gurewich, a researcher and Harvard Medical School faculty member since 1965, discovered a breakthrough drug treatment for heart attacks and strokes with the potential to save millions, but institutional resistance and a U.S. healthcare system that puts profits over patients are keeping it out of reach.

The Utah Project on Antitrust and Consumer Protection hosted a conference on the future of consumer financial services law on October 11, 2024, which was supported by an INET grant.

As artificial intelligence reshapes our economy, policymakers must act swiftly to prevent a winner-take-all scenario in the rapidly evolving market for AI foundation models.

In a fresh release from INET’s book series with Cambridge University Press, renowned German economic historian Carl-Ludwig Holtfrerich uncovers the startling truth behind German currency reform usually hailed as the foundation of the post-war German economic miracle: Ludwig Erhard, who cooperated with the Nazis, unjustly claimed the spotlight, overshadowing the real architect, Edward Tenenbaum.

Cybersecurity expert Muayyad Al-Chalabi assesses CrowdStrike’s update failure and its broader implications for cybersecurity in a discussion with Lynn Parramore.

Increasing evidence that the IRA is probably not harming pharmaceutical innovation.

In a candid discussion with INET’s Lynn Parramore, Dr. Phillip Alvelda highlights the imminent dangers of long COVID, criticizing governments and health agencies for ongoing preventable suffering and deaths. *This is Part 2 of a two-part interview.

An ensemble of mechanisms enables cloud hegemons (Microsoft, Google, Amazon) to plan the whole AI knowledge and innovation network by weaponizing interdependence in networks.

Behind bogus promises of job creation and economic growth lies a dangerous agenda to shred social safety nets.